Abstract | PURPOSE: The purpose of the present study was to evaluate the antitumor activity and pharmacokinetic profile of MEN4901/ T-0128 in nude mice bearing human tumor xenografts in comparison with irinotecan (CPT-11) and T-2513. EXPERIMENTAL DESIGN: We have determined the antitumor activity of MEN4901/ T-0128, CPT-11, and T-2513 in BALB/cA Jcl nude mice bearing human gastric (H-81), colon (H-110), lung (Mqnu-1, H-74), esophageal (H-204), liver (H-181), and pancreatic (H-48) cancer lines, which had been serially transplanted s.c. and maintained in nude mice, and characterized the pharmacokinetic profile of MEN4901/ T-0128 in nude mice bearing human gastric carcinoma St-4. RESULTS:
MEN4901/ T-0128 administered i.v. showed a marked antitumor activity in each of these tumor models, producing tumor shrinkage in the models of H-204 and H-181 carcinomas at its maximum tolerated dose of 80 mg/kg (expressed as T-2513) weekly for 4 weeks (q7d x 4) and tumor-shrinking or marked growth-inhibitory effects in the models of H-81, H-110, Mqnu-1, H-74, and H-48 carcinomas at 1/3 of its maximum tolerated dose (q7d x 4). Pharmacokinetic analysis showed that MEN4901/ T-0128 had an extended plasma half-life with sustained tumor levels of T-2513, which may explain the superior activity of MEN4901/ T-0128 in vivo. CONCLUSIONS: Because the efficacies of some drugs in this human cancer-nude mouse panel correlated well with their clinical outcomes in patients with the same type of cancers, the findings provide direct support that MEN4901/ T-0128 is more efficacious than CPT-11 and is an excellent candidate for clinical trials for the treatment of solid tumors.
|
Authors | Fumiko Fujita, Masako Koike, Masahide Fujita, Yasuo Sakamoto, Satoshi Okuno, Takayuki Kawaguchi, Shigeru Yano, Toshiro Yano, Satoko Kiuchi, Toshihisa Fujiwara, Shinzoh Kudoh, Masatoshi Kakushima |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 11
Issue 4
Pg. 1650-7
(Feb 15 2005)
ISSN: 1078-0432 [Print] United States |
PMID | 15746070
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Dextrans
- Irinotecan
- Topotecan
- T 0128
- Camptothecin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacokinetics, pharmacology)
- Area Under Curve
- Body Weight
(drug effects)
- Camptothecin
(analogs & derivatives, pharmacokinetics, pharmacology)
- Cell Line, Tumor
- Dextrans
(chemistry, pharmacokinetics, pharmacology)
- Humans
- Irinotecan
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Time Factors
- Topotecan
(analogs & derivatives, chemistry, pharmacokinetics, pharmacology)
- Treatment Outcome
- Xenograft Model Antitumor Assays
(methods)
|